Can a new malaria vaccine hold the key to reliable, durable protection?

Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies.

GlaxoSmithKline’s Senior Vice President of US Oncology speaks about the pandemic and its impact on patients.

What role can regulators play in overcoming the barriers to the adoption of continuous manufacturing processes?

Creating a patient-centric ecosystem in India.

How pharma can support patients with initial onboarding and ongoing adherence to therapeutic treatments.

Why is there a need for innovation in cell line development technology?

How do we reduce the presence of pharmaceuticals in water?

Steve Bates gives us the inside scoop on the UK’s Vaccine Taskforce.

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.